Denali Therapeutics Inc. (DNLI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.9B |
| Enterprise Value | 2.73B |
| P/E Ratio | -8.74 |
| PEG Ratio | 5.11 |
| Price/Sales Ratio | 1,093.44 |
| Price/Book Ratio | 5.57 |
| Enterprise/Revenue | 1,045.15 |
| Enterprise/EBITDA | -7.48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -141.91 |
| Operating Margin | -150.58 |
| Return On Assets | -0.44 |
| Return On Equity | -0.55 |
| Revenue | 0 |
| Revenue/Share | 0.02 |
| Gross Profit | -11.18M |
| EBITDA | -497.63M |
| Net Income | -512.54M |
| Diluted EPS | -2.97 |
| Total Cash | 710.47M |
| Total Cash/Share | 3.79 |
| Total Debt | 27.51M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 8.37 |
| Book Value Per Share | 4.46 |
| 52-Week Change | 77.87 |
| 52-Week High | 27.3 |
| 52-Week Low | 12.58 |
| Moving Average 50 Days | 23.4 |
| Moving Average 200 Days | 20.03 |
| Average Volume | 1.85M |
| Shares Outstanding | 158.71M |
| % Held by Institutions | 84.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |